Aimco Pesticides LtdQ3 FY24Fertilizers & Agrochemicals

Aimco Pesticides Ltd

Q3 FY24 Earnings Call Analysis

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Revenue guidance

Category 3

→Target revenue for FY26: Over ₹210 crore (Ashit Dave on Q4 and FY26 outlook).
→Brand business revenue target for FY26: ₹200 crore (aim to double in two years).
→Volume growth expectation: 15-20% increase year-on-year.
→Export to domestic sales ratio currently ~50:50, with expectation of export business improvement in FY26.
→New products: Three recently commercialized molecules expected to generate significant revenue from next financial year.
→Capacity utilization: Currently around 70%, with plans to repurpose insecticide plant and consider additional capacity in Q4 FY25.
→Bifenthrin capacity to be fully utilized in next two financial years, driven by Brazil market entry.
→Overall growth dependent on pricing, market conditions, and regulatory registrations, especially in Brazil.
→EBITDA margin expected to remain stable or improve with new high-margin branded products.

Category 3

→Aimco Pesticides expects to be profitable by the end of FY25, with improving Q3 and Q4 performance.
→Revenue target for FY25 is over ₹210 crore, with EBITDA margins expected to improve, though Q4 pricing remains uncertain.
→For FY26, a clearer revenue and EBITDA margin target will be shared next quarter; branded business aims for ₹200 crore revenue by FY26.
→The company plans 15-20% volume growth annually over the next couple of years, aided by new product launches and export market expansion.
→Gross margins for branded formulations are stable at 30-35%, with EBITDA margins around 10%, expected to sustain as product mix improves.
→New products commercial ramp-up and export registrations (e.g., Triclopyr in Brazil in FY26) should enhance growth.
→Capex remains cautious to preserve cash flow, focusing on repurposing existing plants for new products with major capacity expansions deferred till profitability stabilizes.

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Aimco Pesticides Ltd and 1,400+ other companies.

→Currently, there is no mention of any ongoing or planned fundraising through debt or equity.
→The company has put major Capex plans on hold to avoid burdening cash flow during difficult times.
→Future Capex decisions, including investments in additional manufacturing capacity, will be taken cautiously after stabilizing profitability and margins.
→Any large investments or capacity expansions will be evaluated and decided by the board at appropriate times.
→No specific plans for raising funds via equity or debt have been disclosed for FY25 or FY26.

→Significant orders are ongoing in Q3, with volume-wise expectations being satisfactory.
→Q4 order projections are uncertain due to pricing and supply issues, especially from China.
→Negotiations for new export contract products, including a herbicide, are ongoing but not finalized.
→Discussions for Bifenthrin volumes in Brazil are active, expecting significant volume in Q4 and full capacity utilization by FY26.
→Three new products are commercialized and early stage sales have started; significant ramp-up expected in next financial year.
→The company's export orderbook faces pressure from price erosion and competition but volume remains steady.
→Domestic brand business order momentum is strong and growing with expected revenue of ₹130 crore for FY25 and ₹200 crore by FY26.
→Additional capacity decisions for new molecules pending and to be finalized next quarter.

Yes

→Current Capex is on hold to avoid burdening cash flow during difficult times; focus is on stabilizing existing business first.
→Planned Capex for FY25 includes ₹1.5 to 2 crores to repurpose existing manufacturing facilities for a new product (modification and debottlenecking).
→Major Capex proposals (formulation plant and intermediate plant with ~2000 tons capacity) have been deferred to FY26 or beyond, pending profitability and margin improvement.
→Two new formulation plants have been acquired; setting up of a new formulation plant expected next year to add capacity, not to shift existing plant.
→Additional capacity decisions for three new molecules will be made in Q4 FY25 based on market conditions.
→Large-scale capacity expansions for new products anticipated in FY26 after product registrations and market demand improve.
→Board to evaluate and approve any major future plant capacity investments carefully.

How does Aimco Pesticides Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

1Aimco Pesticides Ltd

Rev 3Mar 3

See full Fertilizers & Agrochemicals sector rankings

Want more stocks like Aimco Pesticides Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.